SCHEMBL10130802

SCHEMBL10130802

Nc1n[nH]c2ccc(O)cc12

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 14/20 0.60
PDPK1 O15530 4/20 0.60
KDM4E B2RXH2 1/20 0.52
CYP3A4 P08684 1/20 0.52
GAA P10253 1/20 0.52
JAK1 P23458 4/20 0.47
TYK2 P29597 1/20 0.47
JAK3 P52333 1/20 0.47
HSP90AB1 P08238 1/20 0.47
MAPK1 P28482 1/20 0.46
MAP2K4 P45985 1/20 0.46
MAPKAPK2 P49137 1/20 0.46
MAPKAPK3 Q16644 1/20 0.46
MAPK6 Q16659 1/20 0.46
MAPKAPK5 Q8IW41 1/20 0.46
ESR1 P03372 1/20 0.44
FGFR1 P11362 1/20 0.44
FGFR2 P21802 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10369298 0.98 JAK2 (0.58) JAK2PDPK1KDM4ECYP3A4GAA
SCHEMBL10213932 0.85 JAK2 (0.72) JAK2PDPK1JAK1TYK2JAK3
SCHEMBL10130804 0.83 PDPK1 (0.61) JAK2PDPK1KDM4ECYP3A4GAA
SCHEMBL10213901 0.81 JAK2 (0.71) JAK2PDPK1CYP3A4JAK1TYK2
SCHEMBL8877161 0.80 JAK2 (0.54) JAK2PDPK1KDM4ECYP3A4JAK1
SCHEMBL13810936 0.79 JAK2 (0.52) JAK2PDPK1JAK1TYK2JAK3
SCHEMBL118573 0.78 JAK2 (0.64) JAK2PDPK1KDM4ECYP3A4GAA
SCHEMBL10213929 0.78 JAK2 (0.81) JAK2PDPK1KDM4ECYP3A4GAA
SCHEMBL1663652 0.78 FGFR1 (0.68) JAK2PDPK1HSP90AB1MAPK1MAP2K4
SCHEMBL23062796 0.78 MAP2K4 (0.53) JAK2PDPK1KDM4ECYP3A4GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023186773-A1 SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2023-10-05 WO disclosed
EP-1820503-B1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them PFIZER ITALIA SRL (IT) 2012-02-22 EP disclosed
EP-1432416-B1 AMINOINDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM PFIZER ITALIA SRL (IT) 2011-01-19 EP disclosed
US-7511136-B2 Aminoindazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2009-03-31 US disclosed
US-7511136-B2 Aminoindazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2009-03-31 US disclosed
EP-1820503-A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them Pfizer Italia S.r.l. (IT) 2007-08-22 EP disclosed
EP-0090972-B1 INDAZOLE DERIVATIVES Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1990-05-30 EP disclosed
US-4751302-A ANTIINFLAMMATORY, ANTIULCER AGENTS, ANALGESICS ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1988-06-14 US disclosed
US-4533731-A ANTIINFLAMMATORY AGENTS ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1985-08-06 US disclosed
EP-0090972-A2 Indazole derivatives Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1983-10-12 EP disclosed